KalVista Pharmaceuticals creating a new generation of small molecule protease inhibitors for HAE and DME Hereditary Angioedema (HAE)Diabetic Macular Edema (DME)
News KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results Jul 1, 2020 KalVista Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference May 28, 2020 KalVista Pharmaceuticals to Present at 19th Annual Needham Healthcare Conference Apr 9, 2020 All News
